An Evaluation of the CLINFO Data Management and Analysis System
ResearchPublished 1977
ResearchPublished 1977
Description of the evaluation of the CLINFO prototype data management and analysis system, an interactive minicomputer-based system designed to enable clinical investigators to personally explore and analyze their research data. The evaluation was conducted to assess the system's acceptability, to determine benefits that result from its use, and to identify improvements for future systems. Results indicate that CLINFO prototypes and their support personnel are well accepted, and the systems are heavily used at the three sites in which they have been operating. System users have claimed substantial benefits, including time savings, the ability to analyze more data from a single database, reduced data-manipulation errors, and increased publishable results. System costs appear to be acceptable also. It is concluded that a follow-on CLINFO system should have the same functions and mode of operation as the prototype, but some improvements (described in the report) should be incorporated. (See also R-1541, R-1543-3.)
This publication is part of the RAND report series. The report series, a product of RAND from 1948 to 1993, represented the principal publication documenting and transmitting RAND's major research findings and final research.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.